Skip to main content
SpringerLink
Log in

Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

Zidovudine (formerly azidothymidine) is a potent inhibitor of the human immunodeficiency virus (HIV) reverse transcriptase and represents the first approved drug showing clinical efficacy in HIV-associated diseases. However, considerable toxicity causing macrocytic anemia, neutropenia, and myopathy has been reported, with severe mitochondrial alterations as a special feature of this myopathy. The mitochondrial changes are consistent with the fact that zidovudine acts as an inhibitor of the mitochondrial gamma-polymerase. Electron microscopically, we could confirm the presence of severely altered mitochondria in a 32-year-old male, who developed a necrotizing myopathy after daily administration of 1,000 mg zidovudine over a period of 15 months. In addition, there were even more severe nuclear changes that, for the most part, have not been documented electron microscopically in HIV-related myopathy either with or without zidovudine treatment, especially in non-necrotic and non-regenerating fibers. Since various in vitro studies have shown interference of zidovudine with nuclear DNA metabolism even in human cell lines, we assume that the nuclear changes that we observed are at least in part related to zidovudine treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Avramis VI, Markson W, Jackson RL, Gomperts E (1989) Biochemical pharmacology of zidovudine in human T-lymphoblastoid cell (CEM). AIDS 3:417–422

    Google Scholar 

  2. Balzarini J, Pauwels R, Baba M, Herdewijn P, De Clerko E, Broder S, Johns DG (1988) The in vitro and in vivo antiretro-virus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol 37:897–903

    Google Scholar 

  3. Banker BQ (1975) Dermatomyositis of childhood. Ultrastructural alterations of muscle and intramuscular blood vessels. J Neuropathol Exp Neurol 33:46–75

    Google Scholar 

  4. Barré-Sinoussi F, Chermann JC, Rey R, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Brun-Vézinet F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotrophic retrovirus from a patient at risk for aquired immune deficiency syndrome (AIDS). Science 220:868–871

    Google Scholar 

  5. Bessen LJ, Greene JB, Louie E, Seitzman P, Weinberg H (1988) Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med 318:708

    Google Scholar 

  6. Bhalla K, Birkhofer M, Grant S, Graham G (1989) The effect of recombinant human granulocyte-macrophage colonystimulating factor (rGM-CSF) in 3′-azido-3′-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Exp Hematol 17:17–20

    Google Scholar 

  7. Bolden A, Noy GP, Weissbach A (1977) DNA polymerase of mitochondria is a gamma-polymerase. J Biol Chem 252:3352–3356

    Google Scholar 

  8. Byars N, Kidson C (1975) DNA chain termination by 2′,3′-dideoxythymidine in replicating mammalian cells. Biochemistry 14:3159–3164

    Google Scholar 

  9. Carpenter S, Karpati G (1984) Pathology of skeletal muscle. Churchill Livingstone, New York

    Google Scholar 

  10. Cheng Y-C, Dutschman GE, Bastow KF, Sarngadharan MG, Ting RYC (1987) Human immunodeficiency reverse transcriptase. J Biol Chem 262:2187–2189

    Google Scholar 

  11. Collen JP (1987) Dermatomyositis. Dis Mon 33:263–264

    Google Scholar 

  12. Dalakas MC, Pezeshkpour GH (1988) Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 23 [Suppl]:S38-S48

    Google Scholar 

  13. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by longterm zidovudine therapy. N Engl J Med 322:1098–1105

    Google Scholar 

  14. De Miranda P, Weller S, Maha M (1989) Pharmacokinetics of zidovudine (ZVD) and acyclovir (ACV) during concurrent administration in asymptomatic men with HIV-infection. The 4th International Conference on AIDS, Stockholm, Acta Pathol Microbiol Immunol Scand 97 [Suppl 8]: abstr no 3136

  15. Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon D, De Truchis P, Leport C, Bouvet E, Pazza MC, Levacher M, Regnier B (1988) Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet II:1297–1302

    Google Scholar 

  16. Emura M (1978) Morphological studies on the development of tracheal epithelium in the Syrian golden hamster. IV. Electron microscopy: Blebbing of nuclear membrane. Z Versuchstierkd 20:163

    Google Scholar 

  17. Fardeau M, Tomé FMS (1981) Non-neoplastic disorders of skeletal muscle. In: Johannessen (ed) Electron microscopy in human medicine, vol 4. McGraw-Hill, New York, pp 257–319

    Google Scholar 

  18. Fiddian AP (1988) Zidovudine plus or minus acyclovir in patients with AIDS or ARC. The 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, abstr no 348

  19. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Scooley RT, Jackson GG, Durack DT, King D (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 317:185–191

    Google Scholar 

  20. Fischl MA, Richman DD, Causey DM, Grieco MH, Bryson Y, Mildvan D, Laskin OL, Groopman JE, Volberding PA, Scooley RT, Jackson GG, Durack DT, Andrews JC, Nusinoff-Lehrmans, Barry DW (1989) Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 262:2405–2410

    Google Scholar 

  21. Fukuyama K, Epstein WL (1971) Inhibition of RNA and protein synthesis in granular cells by actinomycin-D and puromycin. J Invest Dermatol 56:211–222

    Google Scholar 

  22. Furman PA, Fyfe JA, St. Clair MA, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H, Barry DW (1986) Phosphorylation of 3′ azido-3′deoxythymidine and selective interaction with human immunodeficiency reverse transcriptase. Proc Natl Acad Sci USA 83:8333–8337

    Google Scholar 

  23. Gabbai AA, Schmidt B, Castelo A, Oliveira ASB, Lima JGC (1990) Muscle biopsy in AIDS and ARC: analysis of 50 patients. Muscle Nerve 13:541–544

    Google Scholar 

  24. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TL, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PD (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500–503

    Google Scholar 

  25. Gamboa ET, Eastwood AB, Hays Ap, Maxwell J, Penn AS (1979) Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 29:1323–1335

    Google Scholar 

  26. Gertner E, Thurn JR, Williams DN, Simpson M, Belfour HH, Rhame F, Henry K (1988) Zidovudine-associated myopathy. Am J Med 86:814–818

    Google Scholar 

  27. Ghadially FN (1988) Ultrastructural pathology of the cell and matrix, vol 1, 3rd edn. Butterworths, London, pp 1–158

    Google Scholar 

  28. Gorard DA, Henry K, Giloff RJ (1988) Necrotizing myopathy and zidovudine. Lancet I:1050

    Google Scholar 

  29. Halger DN, Frame PT (1986) Azidothymidine neurotoxicity (letter). Lancet II:1392–1393

    Google Scholar 

  30. Hantai D, Fournier J-G, Vazeux R, Collin H, Baudrimont M, Fardeau M (1991) Sceletal muscle involvement in human immunodeficiency virus infection. Acta Neuropathol 81:496–502

    Google Scholar 

  31. Helbert M, Fletcher T, Peddle B, Harris JRW, Pinching AJ (1988) Zidovudine-associated myopathy. Lancet II:689–690

    Google Scholar 

  32. Hodak E, Gadoth N, David M (1986) Muscle damage induced by isoretinoin. Br Med J 293:425–426

    Google Scholar 

  33. Huang P, Farquhar D, Plunkett W (1990) Selective action of 3′-azido-3′deoxythymidine 5′-triphosphate on viral reverse transcriptases and human DNA-polymerases. J Biol Chem 265:11914–11918

    Google Scholar 

  34. Jézéquel AM, Shreeve MM, Steiner JW (1967) Segregation of nucleolar components in mycoplasma-infected cells. Lab Invest 16:287–304

    Google Scholar 

  35. Kurth R (1988) Das erworbene Immunmangelsyndrom AIDS. In: Brandis H, Pulverer G (eds) Medizinische Mikrobiologie, 6th edn. Gustav Fischer Verlag. Stuttgart, pp 723–732

    Google Scholar 

  36. Lange DJ, Rubin M, Britton CB, Hays AP, Yuonger DS (1990) Disorders of peripheral nerves associated with HIV infection. Clin Podiatr Med Surg 7:71–81

    Google Scholar 

  37. MacDonell, Murphy R, Sahgal V, Skoutelis A, Phair JP (1989) Myopathy associated with HIV infection and zidovudine therapy. CDC AIDS Weekly 16:23

    Google Scholar 

  38. Mastaglia FL (1980) Drug-induced disorders of muscle. Br J Hosp Med 23:8–16

    Google Scholar 

  39. Matthes E, Lehman C, Scholz D, v.Janta-Lipinski M, Gaertner K, Rosenthal HA, Langen P (1987) Inhibition of HIV associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular polymerases alpha and beta. Biochem Biophys Res Commun 148:78–85

    Google Scholar 

  40. Melamed AJ, Muller RJ, Gold JWM, Wise Campbell S, Kleinberg ML, Armstrong D (1987) Possible zidovudine-induced hepatoxicity (letter). JAMA 258:2063

    Google Scholar 

  41. Mhiri C, Baudriment M, Bonne G, Geny Degoul F, Marsac C, Roullet E, Gherardi R (1991) Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29:606–614

    Google Scholar 

  42. Munch-Petersen B (1988) Azidothymidine inhibits mitogenstimulated growth and DNA repair in human peripheral lymphocytes. Biochem Biophys Res Commun 157:1369–1375

    Google Scholar 

  43. Nordstrom DM, Petropolis AA, Giorno R, Gates RH, Reddy VB (1989) Inflammatory myopathy and aquired immune deficiency syndrome. Arthritis Rheum 32:475–479

    Google Scholar 

  44. Panegyres PK, Tan N, Kakulas BA, Armstrong JA (1988) Necrotizing myopathy and zidovudine. Lancet I:1050–1051

    Google Scholar 

  45. Panegyres PK, Papadimitriou JM, Hollingsworth PN, Armstrong JA, Kakulas BA (1990) Vesicular changes in the myopathies of AIDS. Ultrastructurral observations and their relationship to zidovudine treatment. J Neurol Neurosurg Psachiatry 53:649–655

    Google Scholar 

  46. Parker WB, White EL, Shaddix SC, Ross LJ, Buckheit RW, Germany JM, Secrist JA, Vince R, Shannon WM (1991) Mechanism of inhibition of human immunodeficiency virus type I reverse transcriptase and human DNA-polymerases alpha, beta and gamma by the 5′triphosphates of carbovir, 3′-azido-3′-deoxythymidine, 2′,3′-dideoxyguanosine, and 3′-deoxythymidine. J Biol Chem 266:1754–1762

    Google Scholar 

  47. Popovic M, Sarnpadharan MG, Read E, Gallo RC (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500

    Google Scholar 

  48. Reddy J, Svoboda D (1968) The relationship of nucleolar segregation to ribonucleic acid synthesis following the administration of selected hepatocarcinogens. Lab Invest 19:132–145

    Google Scholar 

  49. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Nusinoff-Lehrman S (1987) The toxicity of azidothymidine (AZT) in treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 317:192–197

    Google Scholar 

  50. Scanlon KJ, Kashani-Sabet M, Sowers LC (1989) Overexpression of DNA replication and repair enzymes in cisplatinresistant human colon carcinoma HCT8 cells and circumvention by azidothymidine. Cancer Commun 1:269–275

    Google Scholar 

  51. Schröder JM (1982) Pathologie der Muskulatur. In: Doerr J, Seifert G, Uehlinger E (eds) Spezielle pathologische Anatomie, vol 15. Springer, Berlin Heidelberg New York p 301

    Google Scholar 

  52. Schröder JM, Krämer KG, Hopf HC (1985) Granular nuclear inclusion body disease: fine structure of tibial muscle and sural nerve. Muscle Nerve 8:52–59

    Google Scholar 

  53. Scovassi AI, Wicker R, Bertazzoni U (1979) A phylogenetic study on vertebrate mitochondrial DNA polymerase. Eur J Biochem 100:491–496

    Google Scholar 

  54. Simpson MV, Chin CD, Keilbaugh SA, Lin T-S, Prusoff WH (1989) Studies on the inhibition of mitochondrial DNA-replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication. Biochem Pharmacol 38:1033–1036

    Google Scholar 

  55. Sistori C, Bosisio M (1966) Oncolysis by herpes simplex. Lancet I:96

    Google Scholar 

  56. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB (1983) Neurological complications of aquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 14:403–418

    Google Scholar 

  57. Sommadossi J-P, Carlisle R (1987) Toxicity of 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-3-propoxymethyl) guanine for normal human hematopoietic progenitor cells in vitro. Antimicrob Agents Chemother 31:452–454

    Google Scholar 

  58. Sommadossi J-P, Carlisle R, Zhou Z (1989) Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol Pharmacol 36:9–14

    Google Scholar 

  59. St. Clair MH, Richards CA, Spector T, Weinhold KJ, Miller WH, Langlois AJ, Furman PA (1987) 3′-Azido-3′-deoxythymidine triphosphate and an inhibitor and substrate of purified human immunodeficiency virus revese transcriptase. Antimicrob Agents Chemother 31:1972–1977

    Google Scholar 

  60. Stern R, Gold J, DiCarlo EF (1987) Myopathy complicating the aquired immune deficiency syndrome. Muscle Nerve 10:318–322

    Google Scholar 

  61. Swanson JL, Craighead JE, Reynolds ES (1966) Electron microscopic observations of herpes virus hominis (herpes simplex virus) encephalitis in man. Lab Invest 15:1966–1981

    Google Scholar 

  62. Takahashi K, Ogita T, Okudaira H (1986) d-Penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum 29:560–564

    Google Scholar 

  63. Tomé FMS, Fardeau M (1986) Nuclear changes in muscle disorders. Meth Achiev Exp Pathol 12:261–296

    Google Scholar 

  64. Tyrsted G (1984) Effect of 5-fluoro-2′-deoxyuridine and hydroxyurea on the phythemagglutinin-induced increase of thymidine kinase, replicative DNA polymerase, deoxycytidylate deaminase, and CDP reductase activity in human lymphocytes. Mol Cell Biochem 62:165–174

    Google Scholar 

  65. Watson AJS, Dalbow MH, Stachura I (1983) Immunologic studies in cimetidine-induced nephropathy and polymyositis. N Engl J Med 308:142–145

    Google Scholar 

  66. Wier KA, Fukuyama K, Epstein WL (1971) Nuclear changes during keratinization of normal human epidermis. J Ultrastruct Res 37:138–145

    Google Scholar 

  67. Weidner DA, Sommadossi J-P (1990) 3′-azido-3′-deoxythymidine inhibits globin gene transcription in butyric acidinduced K-962 human leukemia cells. Mol Pharmacol 38:797–804

    Google Scholar 

  68. Weiss M, Meyer J (1972) Comparison of the effects of Coxsackie virus A9 and of actinomycin D on the nucleolar ultrastructure of the monkey kidney cells. J Ultrastruct Res 38:411–419

    Google Scholar 

  69. Wiley CA (1989) Neuromuscular diseases of AIDS. FASEB J 3:2503–2511

    Google Scholar 

  70. Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC (1989) HTLV-I myositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 320:992–995

    Google Scholar 

  71. Wischnitzer S (1974) The nuclear envelope: its ultrastructure and functional significance. Endeavour 33:137–142

    Google Scholar 

  72. Wrzolek MH, Sher JA, Kozlowski PB, Rao C (1990) Skeletal muscle pathology in AIDS: an autopsy study. Muscle Nerve 13:508–515

    Google Scholar 

  73. Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, Gelmann E, Nusinoff Lehrmann S, Blum RM, Barry DW, Shearer GM, Fischl MA, Mitsuya H, Gallo RC, Collins JM, Bolognesi DP, Myers CE, Broder S (1986) Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet I:575–580

    Google Scholar 

  74. Yoshida Y, Yoshida C (1990) Reversal of azidothymidine-induced bone-marrow suppression by 2′,3′-dideoxythymidine as studied by hematopoietic clonal culture. AIDS Res Hum Retroviruses 6:929–932

    Google Scholar 

  75. Zhu Z, Carlisle R, Sommadossi J-P (1988) Studies on mechanism of toxicity of 3′-azido-3′-deoxythymidine (AZT) in human bone marrow (HBM) cells. Intersci Conf Antimicrob Agents Chemother 28:1466

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Insitut für Neuropathologie, Klinikum der Rheinisch-Westfälischen Technischen Hochschule, Pauwelsstrasse 30, W-5100, Aachen, Federal Republic of Germany

    J. M. Schröder & M. Bertram

  2. Institut für Neuropathologie, von Bodelschwinghsche Anstalten Bethel, W-4800, Bielefeld 13, Federal Republic of Germany

    R. Schnabel

  3. Innere Medizin (Klinik Mara II), von Bodelschwinghsche Anstalten Bethel, W-4800, Bielefeld 13, Federal Republic of Germany

    U. Pfaff

Authors
  1. J. M. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bertram
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Schnabel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Pfaff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schröder, J.M., Bertram, M., Schnabel, R. et al. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85, 39–47 (1992). https://doi.org/10.1007/BF00304632

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00304632

Key words

Search

Navigation